Korean J Med.  2014 May;86(5):557-562.

Treatment of Severe Sepsis-Based on Surviving Sepsis Campaign Guideline

Affiliations
  • 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea. sangmin2@snu.ac.kr

Abstract

Sepsis is a systemic, deleterious host response to infection. The term "severe sepsis" is used when sepsis is complicated by acute organ dysfunction, and "septic shock" as sepsis complicated by either hypotension that is refractory to fluid resuscitation or by hyperlactatemia. The number of cases with severe sepsis exceeds 750,000 per year in the United States and the mortality is now closer to 20 to 30% in these days. The principles of the initial management bundle are to provide sufficient hemodynamic resuscitation and early initiation of appropriate antibiotics to mitigate uncontrolled infection. Initial resuscitation requires the use of intravenous fluids and vasopressors. It is very important to achieve the target of initial resuscitation. The supportive cares in ICU are also significant such as blood component transfusion, glucose control, renal replacement therapy, deep vein thrombosis prophylaxis and stress ulcer prophylaxis. The goals of care and prognosis including end-of-life care should be discussed with patients and families as early as feasible.

Keyword

Sepsis; Severe sepsis; Septic shock; Guidelines; Evidence-based medicine; Sepsis bundles

MeSH Terms

Anti-Bacterial Agents
Blood Component Transfusion
Evidence-Based Medicine
Glucose
Hemodynamics
Humans
Hypotension
Mortality
Patient Care Planning
Prognosis
Renal Replacement Therapy
Resuscitation
Sepsis*
Shock, Septic
Ulcer
United States
Venous Thrombosis
Anti-Bacterial Agents
Glucose
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr